Abrdn Life Sciences Investors (HQL)
Market Closed
17 Jul, 20:00
NYSE NYSE Primary NASDAQ (NMS) $
19. 74
+0.01
+0.0507%
$
616.67M Market Cap
- Div Yield
154,305 Volume
$ 19.73
Previous Close 
Want to track HQL and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Abrdn Life Sciences Investors (HQL) Statistics
Valuation metrics
Market Cap 616.67M
Enterprise value 600.25M
Trailing P/E (ttm) 2.92
Forward P/E -
PEG ratio 0
Price/Sales (ttm) 10.05
Price/Book (mrq) 1.07
Enterprise Value/Revenue 10.05
Enterprise Value/EBITDA 3.03
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 136.18K
Average volume (90 days) 107.54K
Price summary
52-Week low 13.01
52-Week high 21.32
Beta -
50-Day moving average 19.95
200-Day moving average 17.27
Dividends and splits
Forward annual dividend rate -
Forward annual dividend yield -
Trailing annual dividend rate 2.04
Trailing annual dividend yield 0.1033%
5-Year annual dividend yield -
Payout ratio 0.25
Dividend Date 30 Jun 2026
Ex-Dividend Date 21 May 2026
Last split factor -
Last split Date -
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin 3.32%
Operating margin 3.32%
Operational effectiveness
Return on assets 0.35%
Return on equity 0.37%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) 1.96
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) 6.52
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 0.03
Total debt (mrq) -
Total Debt/Equity (mrq) -
Current ratio (mrq) 2.58%
Book value per share (mrq) 18.44
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
